Nasdaq:US$13.87 (-1.14) | HKEX:HK$21.25 (-2.30) | AIM:£2.30 (-0.22)
新闻中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科学出版物 | 2010-11-30

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)